1. Point of care, bone marrow mononuclear cell therapy in ischemic heart failure patients personalized for cell potency: 12-month feasibility results from CardiAMP heart failure roll-in cohort. (1st March 2021) Authors: Raval, Amish N.; Johnston, Peter V.; Duckers, Henricus J.; Cook, Thomas D.; Traverse, Jay H.; Altman, Peter A.; Dhingra, Ravi; Hematti, Peiman; Borrello, Ivan; Anderson, R. David; Pepine, Carl J. Journal: International journal of cardiology Issue: Volume 326(2021) Page Start: 131 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗